The first two conversations in this series focus largely on patients. This one broadens the scope to address what physicians in underserved communities must do to shape a culture of participation and how drug developers and community advocates can support these goals and activities.
TOPICS: Diagnostic Tests, DrugTrial, Global Liver Institute, NAFLD, NASH, Patient Advocacy, population screening, TrialDesign, Medidata, knowRx, patient focused drug development, patient empowerment, GLI Advanced Advocacy Academ
Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast